365
Participants
Start Date
September 6, 2023
Primary Completion Date
April 25, 2025
Study Completion Date
April 25, 2025
mRNA-1608
Sterile liquid for injection
BEXSERO
A vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B.
Rochester Clinical Research, Rochester
Health Research of Hampton Roads, Newport News
M3 Wake Research, Inc., Raleigh
Multi-Specialty Research Associates, Inc., Lake City
Suncoast Research Associates, LLC, Miami
Accel Clinical Sites Network - Cahaba Medical Care, Birmingham
Velocity Clinical Research Cleveland, Beachwood
DM Clinical Research, Southfield
Johnson County Clin-Trials (JCCT), Lenexa
Alliance for Multispecialty Research, LLC, Newton
Velocity Clinical Research, Norfolk
Velocity Clinical Research, Grand Island
Research Works, New Orleans
Helios CR, Inc Fort Worth, Fort Worth
DM Clinical Research, Tomball
DM Clinical Research, Houston
Sun Research Institute, San Antonio
Velocity Clinical Research, Austin, Cedar Park
Noble Clinical Research, Tucson
Cedars-Sinai Medical Center/Carbon Health, Beverly Hills
Acclaim Clinical Research, San Diego
University of Washington Virology Research Clinic, Seattle
Fenway Health, Boston
ModernaTX, Inc.
INDUSTRY